AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.9375
0.00 (0.00%)
Apr 8, 2026, 4:19 AM EDT - Market open

AEON Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2023FY 2022
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Jun '23 Dec '22
241322268--
Market Cap Growth
3087.65%-38.34%-91.93%---
Enterprise Value
56.4645.834.42262.3900
Last Close Price
0.941.1038.88518.40--
PE Ratio
--0.280.5311.08--
PB Ratio
--0.24-0.76-1.25--
P/TBV Ratio
-0.17-0.20-0.78-1.25--
P/FCF Ratio
--0.77-1.06---
P/OCF Ratio
--0.77-1.06---
EV/EBITDA Ratio
--3.600.47-0.79--
EV/EBIT Ratio
--3.580.47-0.79--
EV/FCF Ratio
--2.65-1.70---
Debt / Equity Ratio
-0.65-0.65-0.450--0.45
Debt / EBITDA Ratio
-2.79-2.790.18---3.86
Debt / FCF Ratio
-2.05-2.05-0.63---13.08
Net Debt / Equity Ratio
-0.59-0.59-0.450.02--0.45
Net Debt / EBITDA Ratio
-2.55-2.550.180.02--3.85
Net Debt / FCF Ratio
-1.88-1.88-0.63---13.06
Quick Ratio
0.440.440.000.40-0.00
Current Ratio
0.490.490.110.48-0.11
Return on Equity (ROE)
93.84%93.84%-46.26%423.57%2692.65%-44.63%
Return on Assets (ROA)
-294.28%-294.25%1461.60%-6691.83%-21270.30%-185.93%
Return on Invested Capital (ROIC)
166.69%166.67%-652.18%2985.94%6064.55%53.01%
Return on Capital Employed (ROCE)
207.45%207.44%-848.12%3883.06%6071.71%60.43%
Earnings Yield
-165.34%-359.09%187.58%9.03%--
FCF Yield
-72.98%-130.00%-93.95%0.00%--
Buyback Yield / Dilution
-1622.66%-1622.66%-11.59%0.00%73.24%99.89%
Total Shareholder Return
-1622.66%-1622.66%-11.59%0.00%73.24%99.89%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q